Evolutionary deimmunization: An ancillary mechanism for self-tolerance?

Cellular Immunology

Volumn 244, Issue 2, 2006, Pages 148-153

  De Groot, Anne S ^a,b   Goldberg, Miriam ^a   Moise, Leonard ^a   Martin, William ^a  

^a EpiVax Inc   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Autologous protein; Epitope mapping; HLA antigens; MHC binding peptide; T cell epitope

Indexed keywords

CELL PROTEIN; EPITOPE;

AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; HLA SYSTEM; HUMAN; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; T LYMPHOCYTE;

BLOOD PROTEINS; COMPUTATIONAL BIOLOGY; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; EVOLUTION, MOLECULAR; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE SYSTEM; SELF TOLERANCE;

EID: 34248403750     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.02.006     Document Type: Article

References (27)

1. Bluestone J.A., and Abbas A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. (2003) 253-257
2. Jiang X., and Moudgil K.D. The unveiling of hidden T-cell determinants of a native antigen by defined mediators of inflammation: implications for the pathogenesis of autoimmunity. Scand. J. Immunol. 63 (2006) 338-346
3. Page K.R., Scott A.L., and Manabe Y.C. The expanding realm of heterologous immunity: friend or foe?. Cell Microbiol. 8 (2006) 185-196
4. De Groot A.S., and Berzofsky J.A. From genome to vaccine-new immunoinformatics tools for vaccine design. Methods 34 (2004) 425-428
5. Ahlers J.D., Belyakov I.M., Thomas E.K., and Berzofsky J.A. High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection. J. Clin. Invest. 108 (2001) 1677-1685
6. De Groot A.S., Sbai H., Saint-Aubin C., McMurry J.A., and Martin W. Immuno-informatics: mining genomes for vaccine components. Immunol. Cell Biol. 80 (2002) 255-269
7. Inaba H., Martin W., De Groot A.S., Qin S., and De Groot L.J. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease. J. Clin. Endocrinol. Metab. 91 (2006) 2286-2294
8. De Groot A.S., Jesdale B.M., Szu E., Schafer J.R., Chicz R.M., and Deocampo G. An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. AIDS Res. Hum. Retroviruses 13 (1997) 529-531
9. Bond K.B., Sriwanthana B., Hodge T.W., De Groot A.S., Mastro T.D., Young N.L., Promadej N., Altman J.D., Limpakarnjanarat K., and McNicholl J.M. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected thais. AIDS Res. Hum. Retroviruses 20 (2001) 703-717
10. McMurry J., Sbai H., Gennaro M.L., Carter E.J., Martin W., and De Groot A.S. Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes. Tuberculosis (Edinb.) 85 (2005) 95-105
11. Dong Y., Demaria S., Sun X., Santori F.R., Jesdale B.M., De Groot A.S., Rom W.N., and Bushkin Y. HLA-A2-restricted CD8+cytotoxic- T cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase. Infect. Immun. 72 (2004) 2412-2415
12. Koita O.A., Dabitao D., Mahamadou I., Tall M., Dao S., Tounkara A., Guiteye H., Noumsi C., Thiero O., Kone M., Rivera D., McMurry J.A., Martin W., and De Groot A.S. Confirmation of immunogenic consensus sequence HIV-1 T cell epitopes in Bamako, Mali and Providence, Rhode Island. Hum. Vaccin. (2006) 119-128
13. De Groot A.S. Immunomics: Discovering new targets for vaccine and therapeutics. Drug Discov. Today 11 (2006) 203-209
14. Chicz R.M., and Urban R.G. Analysis of MHC-presented peptides: applications in autoimmunity and vaccine development. Immunol. Today 15 (1994) 155-160
15. Wu C.H., Apweiler R., Bairoch A., Natale D.A., Barker W.C., Boeckmann B., Ferro S., Gasteiger E., Huang H., Lopez R., Magrane M., Martin M.J., Mazumder R., O'Donovan C., Redaschi N., and Suzek B. The Universal Protein Resource (UniProt): an expanding universe of protein information. Nucleic Acids Res. 34 (2006) D187-D191
16. Ashburner M., Ball C.A., Blake J.A., Botstein B., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., and Sherlock G. Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25 (2000) 25-29
17. The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat. Genet. 25 (2000) 25--29.
18. Bendtsen J.D., Nielsen H., von Heijne G., and Brunak S. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340 (2004) 783-795
19. De Groot A.S., Rayner J., and Martin B. Modeling the immunogenicity of therapeutic proteins using T cell epitope mapping. In: Brown F., and Suis A.M. (Eds). Immunogenicity of Therapeutic Biological Products Developments in Biologicals vol. 112 (2003), Karger, Basel 71-80
20. Hema Thanka Christlet T., and Veluraja K. Database analysis of O-glycosylation sites in proteins. Biophys. J. 80 (2001) 952-960
21. Scanlan M.J., and Jager D. Challenges to the development of antigen-specific breast cancer vaccines. Breast Cancer Res. 3 (2001) 95-98
22. Mullbacher A. Viral escape from immune recognition: multiple strategies of adenoviruses. Immunol. Cell Biol. 70 (1992) 59-63
23. Hill A.V., Jepson A., Plebanski M., and Gilbert S.C. Genetic analysis of host-parasite coevolution in human malaria. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 352 (1997) 1317-1325
24. Vossen M.T., Westerhout E.M., Soderberg-Naucler C., and Wiertz E.J. Viral immune evasion: a masterpiece of evolution. Immunogenetics 54 (2002) 527-542
25. Istrail S., Florea L., Halldorsson B.V., Kohlbacher O., Schwartz R.S., Yap V.B., Yewdell J.W., and Hoffman S.L. Comparative immunopeptidomics of humans and their pathogens. PNAS 101 (2004)
26. Parker K.C., Bednarek M.A., and Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152 (1994) 163-175
27. De Groot A.S., Knopf P.M., and Martin B. De-immunization of therapeutic proteins by T cell epitope modification. In: Mire-Sluis A. (Ed). State of the Art Analytical Methods for the Characterization of Biological Products and Assessment of Comparabilitiy. Dev. Biol. vol. 122 (2005), Karger, Basel 137-160